Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
15.8%
operating margin TTM
5.54%
revenue TTM
310.50 Million
revenue per share TTM
5.68$
valuation ratios | |
|---|---|
| pe ratio | 8.95 |
| peg ratio | 0.06 |
| price to book ratio | 0.70 |
| price to sales ratio | 1.34 |
| enterprise value multiple | 20.24 |
| price fair value | 0.70 |
profitability ratios | |
|---|---|
| gross profit margin | 77.42% |
| operating profit margin | 5.54% |
| pretax profit margin | 16.35% |
| net profit margin | 15.8% |
| return on assets | 6.07% |
| return on equity | 8.33% |
| return on capital employed | 2.38% |
liquidity ratio | |
|---|---|
| current ratio | 8.45 |
| quick ratio | 8.45 |
| cash ratio | 2.55 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 43.83 |
| days of payables outstanding | 31.19 |
| cash conversion cycle | 12.64 |
| receivables turnover | 8.33 |
| payables turnover | 11.70 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.11 |
| debt equity ratio | 0.14 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.12 |
| interest coverage | 0.00 |
| cash flow to debt ratio | -0.59 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.53 |
| cash per share | 5.97 |
| operating cash flow per share | -0.46 |
| free cash flow operating cash flow ratio | 1.15 |
| cash flow coverage ratios | -0.59 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -6.47 |
Frequently Asked Questions
When was the last time Voyager Therapeutics, Inc. (NASDAQ:VYGR) reported earnings?
Voyager Therapeutics, Inc. (VYGR) published its most recent earnings results on 12-11-2024.
What is Voyager Therapeutics, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Voyager Therapeutics, Inc. (NASDAQ:VYGR)'s trailing twelve months ROE is 8.33%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Voyager Therapeutics, Inc. (VYGR) currently has a ROA of 6.07%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did VYGR's net profit margin stand at?
VYGR reported a profit margin of 15.8% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is VYGR's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 8.45 in the most recent quarter. The quick ratio stood at 8.45, with a Debt/Eq ratio of 0.14.